| 2023-09-08 |
复牌提示：
2023-09-07 19:50:01 停牌，复牌日期 2023-09-11 00:00:01
|
| 2023-09-08 |
详情>>
内部人交易：
ROSS ROBERT W.等共交易7笔
|
| 2023-08-02 |
详情>>
股本变动：
变动后总股本6082.45万股
|
| 2023-08-02 |
详情>>
业绩披露：
2023年中报每股收益-0.79美元,归母净利润-4793.3万美元,同比去年增长-152.09%
|
| 2023-07-26 |
股东大会：
将于2023-09-07召开股东大会
会议内容 ▼▲
- 1.To vote on a proposal to adopt the Agreement and Plan of Merger, dated June 15, 2023, by and among Coherus BioSciences, Inc. (“Coherus”), Crimson Merger Sub I, Inc., a direct, wholly owned subsidiary of Coherus, Crimson Merger Sub II, LLC, a direct, wholly owned subsidiary of Coherus, and Surface (as it may be amended from time to time, the “Merger Agreement”), a copy of which is attached as Annex A to the enclosed proxy statement/prospectus (the “Surface merger proposal”);
2.To vote on a proposal to approve, on an advisory (non-binding) basis, the compensation that will or may be paid to Surface’s named executive officers in connection with the Mergers (as defined in the section titled “About this Proxy Statement/Prospectus” of the enclosed proxy statement/prospectus) (the “Surface advisory compensation proposal”);
3.To vote on a proposal to approve the adjournment or postponement of the Surface special meeting to solicit additional proxies if there are not sufficient votes cast at the Surface special meeting to approve the Surface merger proposal or to ensure that any supplemental or amended disclosure, including any supplement or amendment to the enclosed proxy statement/prospectus, is timely provided to Surface stockholders (the “Surface adjournment proposal”).
|
| 2023-05-04 |
详情>>
业绩披露：
2023年一季报每股收益-0.33美元,归母净利润-1974.1万美元,同比去年增长-418.45%
|
| 2023-03-09 |
详情>>
业绩披露：
2022年年报每股收益-1.14美元,归母净利润-6358.6万美元,同比去年增长18.98%
|
| 2023-03-09 |
详情>>
业绩披露：
2020年年报每股收益1.67美元,归母净利润5933.70万美元,同比去年增长208.30%
|
| 2022-11-02 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.78美元,归母净利润-4225.4万美元,同比去年增长22.38%
|
| 2022-08-03 |
详情>>
业绩披露：
2022年中报每股收益-0.37美元,归母净利润-1901.4万美元,同比去年增长44.95%
|
| 2022-05-09 |
详情>>
业绩披露：
2021年一季报每股收益-0.37美元,归母净利润-1556.1万美元,同比去年增长-168.95%
|
| 2022-05-09 |
详情>>
业绩披露：
2022年一季报每股收益0.13美元,归母净利润619.90万美元,同比去年增长139.84%
|
| 2022-04-26 |
股东大会：
将于2022-06-08召开股东大会
会议内容 ▼▲
- 1.To re-elect J. Jeffrey Goater, David S. Grayzel, M.D., and Ramy Ibrahim, M.D. as Class I members of the Board of Directors, to serve until the Company’s 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To transact any other business that may properly come before the meeting or any postponement or adjournment thereof.
|
| 2022-03-02 |
详情>>
业绩披露：
2021年年报每股收益-1.77美元,归母净利润-7848.5万美元,同比去年增长-232.27%
|
| 2021-11-04 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-1.25美元,归母净利润-5443.5万美元,同比去年增长-579.5%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-05 |
详情>>
业绩披露：
2021年中报每股收益-0.81美元,归母净利润-3454.2万美元,同比去年增长-544.96%
|
| 2021-04-27 |
股东大会：
将于2021-06-08召开股东大会
会议内容 ▼▲
- 1.To re-elect Geoffrey McDonough, M.D., Laurie D. Stelzer and Elliott Sigal, M.D., Ph.D. as Class III members of the Board of Directors, to serve until the Company’s 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2020-05-28 |
股东大会：
将于2020-06-10召开股东大会
会议内容 ▼▲
- 1.To re-elect Daniel S. Lynch and Armen B. Shanafelt, Ph.D. as Class II members of the Board of Directors, to serve until the Company’s 2023 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.To transact any other business that may properly come before the meeting or any adjournment thereof.
|
| 2019-04-19 |
股东大会：
将于2019-06-05召开股东大会
会议内容 ▼▲
- 1.To elect J. Jeffrey Goater and David S. Grayzel, M.D. as Class I members of the Board of Directors, to serve until the Company’s 2022 Annual Meeting of Stockholders and until their successors are duly elected and qualified;
2.To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.To transact any other business that may properly come before the meeting or any adjournment thereof.
|